French medical device start-up CarThera has published clinical trial results for using its ultrasound implant to open the blood-brain barrier in patients with recurrent brain tumors.
Each year, the Foundation’s Global Internship Program offers students who are interested in focused ultrasound the opportunity to work with esteemed mentors in the field.
Ying Meng and Nir Lipsman of Sunnybrook Health Sciences Centre discuss the unique challenges presented by Alzheimer’s disease and how focused ultrasound might be the answer.
Researchers, industry professionals, and patients attended a workshop on new FDA guidance for including patients with brain metastases in clinical trial enrollment.
Houston’s Forward Times reports on Victor Murray, a NASA engineer who was diagnosed with prostate cancer in 2017 and decided to undergo focused ultrasound treatment.
In August, the Society for Neuro-Oncology (SNO) will hold its first conference on brain metastases, providing an opportunity to share focused ultrasound work with others in the metastatic brain cancer community.
Researchers from Pohang University of Science and Technology in South Korea sought to develop a novel technique to measure the temperature at the site of focused ultrasound delivery.
With new clinical trial results published and a follow-up study underway, CarThera is making strides in treating patients with serious brain tumors. We interviewed their Scientific Director, Michael Canney, PhD, to learn more about this dynamic company.
Michigan-based HistoSonics has closed a $54 million Series C financing which will allow HistoSonics to complete regulatory and commercial milestones and expand its RASTSM platform.
The Agency for the Safety of Medicines has authorized Cardiawave to begin focused ultrasound clinical trials in France and the Netherlands to treat calcific aortic stenosis.
Mirabilis Medical, Inc., the developer of a noninvasive therapeutic ultrasound system for uterine fibroids, has appointed Wayne Poll, MD, as their new CEO.
